Europe
Roivant Sciences teamed with Cincinnati Children’s Hospital Medical Center to launch Aruvant Sciences. Roivant is the umbrella company run by Vivek Ramaswamy, which has launched a number of companies with “vant” in the names.
The U.S. Food and Drug Administration (FDA) gave the green light late Monday to Bayer oncology drug Vitrakvi, a first-of-its-kind TRK inhibitor, after late-stage clinical trial results showed a 75 percent overall response rate and 22 percent complete response rate across various solid tumors.
Three oral presentations highlighted analyses from the PEPITES Phase III study
Auris Medical Holding AG today announced the results of its pre-Investigational New Drug (pre-IND) meeting with the United States Food & Drug Administration (FDA), where the FDA addressed the Company’s questions and provided guidance on its AM-201 program with intranasal betahistine for the prevention of olanzapine-induced weight gain.
Bill & Melinda Gates Foundation increases RIPE project investment to complement support from FFAR and DFID to improve yields for farmers worldwide
Monocl reaches one of its most significant milestones to date, less than three years post launch
Revenue of $7.5 Billion Increased 6.1% Reported; Increased 7.5% Organic
Asceneuron SA announced today it has commenced a new clinical trial of its lead asset, ASN120290.
Oculis announces the appointments of Fabio Baschiera PharmD, MPh, Ph.D. as Vice President of Clinical Development, and Louie-Anne Gauthier M.Sc., as Vice President of Strategic Marketing, Business Development and Licensing.
Medigene AG today announced its participation at the following upcoming investor and scientific conferences
PRESS RELEASES